Publications by authors named "Elisa Albi"

Claim this Profile
T
Targetable Mutations in V600E-Negative Hairy-Cell Leukemia.
Alessia Santi, Alessandra Venanzi, Alessandra Pucciarini, Gianluca Schiavoni, Marta Naccari, Elisa Albi

N Engl J Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of CYLD promotes splenic marginal zone lymphoma.
Athanasios Pseftogas, Jessica Bordini, Silvia Heltai, Ferdinando Bonfiglio, Georgios Gavriilidis, Elisa Albi

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL.
Thomas Chatzikonstantinou, Lydia Scarfò, Eva Minga, Georgios Karakatsoulis, Dimitra Chamou, Elisa Albi

Hemasphere· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study.
Paolo Sportoletti, Luca Laurenti, Annalisa Chiarenza, Gianluca Gaidano, Elisa Albi

Hematol Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.
Lydia Scarfò, Silvia Heltai, Elisa Albi, Eloise Scarano, Luana Schiattone

Blood· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia.
Elisa Albi, Antonella Capasso, Luana Schiattone, Paolo Ghia, Lydia Scarfò

Semin Cancer Biol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia.
Beatrice Del Papa, Stefano Baldoni, Erica Dorillo, Filomena De Falco, Chiara Rompietti, Elisa Albi

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH1 Aberrations in Chronic Lymphocytic Leukemia.
Emanuela Rosati, Stefano Baldoni, Filomena De Falco, Beatrice Del Papa, Erica Dorillo, Elisa Albi

Front Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.
Mauro Di Ianni, Stefano Baldoni, Beatrice Del Papa, Patrizia Aureli, Erica Dorillo, Elisa Albi

Front Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic/mutation profile of chronic lymphocytic leukemia/malignant melanoma collision tumors of the skin.
Roberta La Starza, Tiziana Pierini, Lorenza Pastorino, Elisa Albi, Caterina Matteucci

Mol Cytogenet· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome.
Elisa Albi, Stefano Baldoni, Patrizia Aureli, Erica Dorillo, Beatrice Del Papa

Tumori· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis